Citations

Clear

6274 citation(s) found for "To, Andrew".

Epidemiology of Lumbar Spine Injuries in Men’s and Women’s National Collegiate Athletic Association Basketball Athletes
Makovicka, Justin L. , Deckey, David G. , Patel, Karan A. , Chung, Andrew S. , Hydrick, Thomas C. , Pena, Austin, Hassebrock, Jeffrey D. , Patel, Karan , Chung, Andrew , Tummala, Sailesh V , Tummala, Sailesh V. , Chhabra, Anikar

Mayo Clinic

Orthopaedic Journal of Sports Medicine | October 31, 2019 | Volume: 7 | Issue: 10 | Pages: No page available

10.1177/2325967119879104 | PMID 31700939 Get It

Background: Lumbar spine injuries (LSIs) are common in both men’s and women’s National Collegiate Athletic Association (NCAA) basketball players and can frequently lead to reinjuries and persistent pain. Purpose: To describe the epidemiology of an LSI in collegiate men’s and women’s basketball during the 2009-2010 through 2013-2014 academic years. Study Design: Descriptive epidemiology study. Methods: The incidence and characteristics of LSIs were identified utilizing the NCAA Injury Surveillance Program (ISP). Rates of injury were calculated as the number of injuries divided by the total number of athlete-exposures (AEs). AEs were defined as any student participation in 1 NCAA-sanctioned practice or competition. Incidence rate ratios (IRRs) were then calculated to compare the rates of injury between season, event type, mechanism, injury recurrence, and time lost from sport. Results: The NCAA ISP reported 124 LSIs from an average of 28 and 29 men’s and women’s teams, respectively. These were used via validated weighting methodology to estimate a total of 5197 LSIs nationally. The rate of LSIs in women was 2.16 per 10,000 AEs, while men suffered LSIs at a rate of 3.47 per 10,000 AEs. Men were 1.61 times more likely to suffer an LSI compared with women. In men, an LSI was 3.48 times more likely to occur in competition when compared with practice, while in women, an LSI was 1.36 times more likely to occur in competition than in practice. Women suffered the highest LSI rate during the postseason, while the highest rate in men was during the regular season. The majority of both female (58.9%; n = 1004) and male (73.1%; n = 2353) athletes returned to play within 24 hours of injury. Conclusion: To date, this is the largest study to characterize LSIs in NCAA basketball and provides needed information on the prevalence and timing of these injuries. The majority of injuries in both sexes were new, and most athletes returned to play in less than 24 hours. Injury rates were highest during competition in both sexes.
Selective YAP/TAZ inhibition in fibroblasts via dopamine receptor D1 agonism reverses fibrosis
Haak, Andrew J. , Kostallari, Enis , Sicard, Delphine , Ligresti, Giovanni , Choi, Kyoung Moo , Caporarello, Nunzia , Jones, Dakota L. , Tan, Qi , Meridew, Jeffrey A., Espinosa, Ana M. Diaz , Aravamudhan, Aja, Maiers, Jessica L. , Britt, Rodney D. , Roden, Anja C. , Prakash, Y. S. , Nouraie, Mehdi , Li, Xiaoyun , Lagares, David , Tager, Andrew M. , Varelas, Xaralabos , Shah, Vijay H. , Tschumperlin, Daniel J. , Zhang, Yingze , Meridew, Jeffrey, Diaz Espinosa, Ana M , Pabelick, Christina M , Prakash, Y S , Nouraie, Seyed Mehdi , Li, Xiaoyun , Zhang, Yingze , Lagares, David , Varelas, Xaralabos , Shah, Vijay H , Tschumperlin, Daniel J , Kostallari, Enis , Caporarello, Nunzia , Ligresti, Giovanni , Pabelick, Christina M. , Kass, Daniel J.

Mayo Clinic

Science Translational Medicine | October 30, 2019 | Volume: 11 | Issue: 516 | Pages: No page available

10.1126/scitranslmed.aau6296 | PMID 31666402 Get It

Pharmacologic stimulation of a G protein–coupled receptor preferentially expressed on fibroblasts reverses experimental lung and liver fibrosis.
The Role of the BCL-2 Family of Proteins in HIV-1 Pathogenesis and Persistence
Chandrasekar, Aswath P. , Cummins, Nathan W. , Badley, Andrew D. , Cummins, Nathan W , Badley, Andrew D

Mayo Clinic

Clinical Microbiology Reviews | October 29, 2019 | Volume: 33 | Issue: 1 | Pages: No page available

10.1128/cmr.00107-19 | PMID 31666279 Get It

Advances in HIV-1 therapy have transformed the once fatal infection into a manageable, chronic condition, yet the search for a widely applicable approach to cure remains elusive. The ineffectiveness of antiretroviral therapy (ART) in reducing the size of the HIV-1 latent reservoir has prompted investigation into the mechanisms of HIV-1 latency and immune escape.
Mechanisms of Human Immunodeficiency Virus-Associated Lymphocyte Regulated Cell Death
Paim, Ana C. , Badley, Andrew D. , Badley, Andrew D , Cummins, Nathan W.

Mayo Clinic

AIDS Research and Human Retroviruses | October 29, 2019 | Volume: 36 | Issue: 2 | Pages: 101-115

10.1089/aid.2019.0213 | PMID 31659912 Get It

Coexistence of Myelin Oligodendrocyte Glycoprotein and Aquaporin-4 Antibodies in Adult and Pediatric Patients
Kunchok, Amy , Chen, John J. , Mills, John R. , Pittock, Sean J. , Pittock, S J , Pittock, Sean J , Chen, John J , McKeon, Andrew , Flanagan, Eoin P.

Mayo Clinic

JAMA Neurology | October 28, 2019 | Volume: 77 | Issue: 2 | Pages: 257

10.1001/jamaneurol.2019.3656 | PMID 31657826 Get It

Infographic. Can even experienced orthopaedic surgeons predict who will benefit from surgery when patients present with degenerative meniscal tears? A survey of 194 orthopaedic surgeons who made 3880 predictions
Bloembergen, Coen H. , Graaf, Victor A. van de , Virgile, Adam , Noorduyn, Julia C. A. , Saris, Daniël B.F. , Poolman, Rudolf W. , van de Graaf, Victor A , Saris, Daniel Bf, Willigenburg, Nienke Willemien , Harris, Ian Andrew

Mayo Clinic

British Journal of Sports Medicine | October 25, 2019 | Volume: 54 | Issue: 9 | Pages: 556-557

10.1136/bjsports-2019-101502 | PMID 31653776 Get It

Anesthesia With and Without Nitrous Oxide and Long-term Cognitive Trajectories in Older Adults
Abcejo, Arnoley S., Petersen, Ronald C. , Hanson, Andrew C. , Schroeder, Darrell R. , Schulte, Phillip J. , Martin, David P. , Pasternak, Jeffrey J., Schroeder, Darrell , Šprung, Juraj , Knopman, David S. , Mielke, Michelle M. , Weingarten, Toby N. , Warner, David O.

Mayo Clinic

Anesthesia & Analgesia | October 25, 2019 | Volume: 131 | Issue: 2 | Pages: 594-604

10.1213/ane.0000000000004490 | PMID 31651458 Get It

BACKGROUND: We evaluated the hypothesis that the rate of postoperative decline in global cognition is greater in older adults exposed to general anesthesia with nitrous oxide (N 2 O) compared to general anesthesia without N 2 O. METHODS: Longitudinal measures of cognitive function were analyzed in nondemented adults, 70–91 years of age, enrolled in the Mayo Clinic Study of Aging. Linear mixed-effects models with time-varying covariates assessed the relationship between exposure to surgery with general anesthesia (surgery/GA) with or without N 2 O and the rate of long-term cognitive changes. Global cognition and domain-specific cognitive outcomes were defined using z scores, which measure how far an observation is, in standard deviations, from the unimpaired population mean. RESULTS: The analysis included 1819 participants: 280 exposed to GA without N 2 O following enrollment and before censoring during follow-up (median [interquartile range {IQR}] follow-up of 5.4 [3.9–7.9] years); 256 exposed to GA with N 2 O (follow-up 5.6 [4.0–7.9] years); and 1283 not exposed to surgery/GA (follow-up 4.1 [2.5–6.4] years). The slope of the global cognitive z score was significantly more negative following exposure to surgery/GA after enrollment (change in slope of −0.062 [95% confidence interval {CI}, −0.085 to −0.039] for GA without N 2 O, and −0.058 [95% CI, −0.080 to −0.035] for GA with N 2 O, both P < .001). The change in slope following exposure to surgery/GA did not differ between those exposed to anesthesia without versus with N 2 O (estimated difference −0.004 [95% CI, −0.035 to 0.026], P = .783). CONCLUSIONS: Exposure to surgery/GA is associated with a small, but statistically significant decline in cognitive z scores. Cognitive decline did not differ between anesthetics with and without N 2 O. This finding provides evidence that the use of N 2 O in older adults does not need to be avoided because of concerns related to decline in cognition.
Vinca alkaloids, thalidomide and eribulin‐induced peripheral neurotoxicity: From pathogenesis to treatment
Islam, Badrul , Lustberg, Maryam B. , Staff, Nathan P. , Kolb, Noah , Alberti, Paola , Argyriou, Andreas A. , Kolb, Noah A , Staff, Nathan P , Lustberg, Maryam

Mayo Clinic

Journal of the Peripheral Nervous System | October 24, 2019 | Volume: 24 | Issue: S2 | Pages: No page available

10.1111/jns.12334 | PMID 31647152 Get It

AbstractVinca alkaloids, thalidomide, and eribulin are widely used to treat patients with childhood acute lymphoblastic leukemia (ALL), adults affected by multiple myeloma and locally invasive or metastatic breast cancer, respectively. However, soon after their introduction into clinical practice, chemotherapy‐induced peripheral neurotoxicity (CIPN) emerged as their main non‐hematological and among dose‐limiting adverse events. It is generally perceived that vinca alkaloids and the antiangiogenic agent thalidomide are more neurotoxic, compared to eribulin. The exposure to these chemotherapeutic agents is associated with an axonal, length‐dependent, sensory polyneuropathy of mild to moderate severity, whereas it is considered that the peripheral nerve damage, unless severe, usually resolves soon after treatment discontinuation. Advanced age, high initial and prolonged dosing, coadministration of other neurotoxic chemotherapeutic agents and pre‐existing neuropathy are the common risk factors. Pharmacogenetic biomarkers might be used to define patients at increased susceptibility of CIPN. Currently, there is no established therapy for CIPN prevention or treatment; symptomatic treatment for neuropathic pain and dose reduction or withdrawal in severe cases is considered, at the cost of reduced cancer therapeutic efficacy. This review critically examines the pathogenesis, epidemiology, risk factors (both clinical and pharmacogenetic), clinical phenotype and management of CIPN as a result of exposure to vinca alkaloids, thalidomide and its analogue lenalidomide as also eribulin.
Chemotherapy‐induced peripheral neurotoxicity: A multifaceted, still unsolved issue
Cavaletti, Guido , Alberti, Paola , Argyriou, Andreas A. , Lustberg, Maryam B. , Staff, Nathan P. , Tamburin, Stefano , Staff, Nathan P , Lustberg, Maryam

Mayo Clinic

Journal of the Peripheral Nervous System | October 24, 2019 | Volume: 24 | Issue: S2 | Pages: No page available

10.1111/jns.12337 | PMID 31647155 Get It

Abstract Chemotherapy‐induced peripheral neurotoxicity (CIPN) is a potentially dose‐limiting side effect of several commonly used cytotoxic chemotherapy agents. The main pharmacological classes that may cause CIPN include classical anticancer drugs, as well as the recently introduced immune checkpoint inhibitors and antibody drug conjugates. The absence of a complete knowledge of CIPN pathophysiology is only one of the several unsolved issues related to CIPN. Among some of the most relevant aspects of CIPN deserving further attention include the real number of patients exposed to the risk of CIPN, the long‐term impact on cancer survivors' quality of life due to incomplete recovery from CIPN, the economic burden related to acute and chronic CIPN, and the different perspective and education of the healthcare specialists in charge of managing patients with CIPN. Overall, CIPN remains a very challenging area of research as there are still several unresolved issues to be addressed in the future. In this special issue, the multifaceted profile of CIPN will be presented, with particular emphasis on bolstering the need to develop more optimized outcome measures than the existing ones to accurately evaluate the extent of CIPN, but also to ascertain the differences in the incidence, risk factors, clinical phenotype, and management of CIPN, according to the most commonly used neurotoxic chemotherapy classes. Perspectives for future research to pursue in order to cover the gaps in knowledge in the CIPN field will also be discussed.